首页 | 本学科首页   官方微博 | 高级检索  
检索        


Detection of BCR-abl in acute leukemia by molecular and cytogenetic methods
Institution:1. Department of Geography, Suleyman Demirel University, 32260 Isparta, Turkey;2. Department of Geological Engineering, Suleyman Demirel University, 32260 Isparta, Turkey;1. National and Kapodistrian University Athens School of Medicine, Athens, Greece;2. University of Melbourne, St Vincent''s Hospital, Fitzroy, VIC, Australia;3. Cancer Research Center, University Hospital Salamanca–Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain;4. Memorial Sloan Kettering Cancer Center, New York, NY, USA;5. Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France;6. John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA;7. University Medical Center Hamburg-Eppendorf, Hamburg, Germany;8. Amgen, Thousand Oaks, CA, USA;9. Atrium Health, Charlotte, NC, USA;1. British Columbia Cancer Agency, Vancouver, BC, Canada;2. University of British Columbia, Vancouver, BC, Canada;3. University of Alberta, Alberta, AB, Canada;4. University Hospital and Masaryk University, Brno, Czech Republic;5. British Columbia Cancer Agency, BC, Canada;6. Charles University, Prague, Czech Republic;7. University Hospital of Bordeaux, CHU Haut-Leveque, Pessac, France;8. University of Texas, Houston, TX, USA;9. CHU de Poitiers, INSERM, Poitiers, France;10. Fred Hutchinson Cancer Research Center, Seattle, WA, USA;11. Hospices Civils de Lyon, Université Claude Bernard Lyon-1, Pierre Bénite, France;12. Queen Mary University of London, London, UK;13. Newcastle University, Newcastle upon Tyne, UK;14. Erasmus MC Cancer Institute, Rotterdam, Netherlands;15. Roche Products Ltd, Welwyn Garden City, UK;p. F Hoffmann-La Roche Ltd, Basel, Switzerland;q. Georgetown University Hospital, Washington, DC, USA;1. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan;2. Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan;3. Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan;4. Division of Hematology/Oncology, Internal Medicine, Kameda Medical Center, Kamogawa, Japan;5. Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan;6. Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;7. Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan;8. Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan;9. Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;10. Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan;11. Department of Hematology, Oita Prefectural Hospital, Oita, Japan;12. Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan;13. Department of Hematology, Oami Municipal Hospital, Oamishirasato, Japan;14. Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan;15. Department of Clinical Oncology, Nagoya Memorial Hospital, Nagoya, Japan;p. Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan;q. Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan;r. Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan;s. Division of Hematology, Tochigi Cancer Center, Utsunomiya, Japan;t. Department of Hematology, Daini Osaka Police Hospital, Osaka, Japan;u. Department of Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan;v. Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan;w. Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan;x. Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan;y. Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan;z. Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan;11. International Medical Center, Saitama Medical University, Hidaka, Japan;12. Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan;13. Division of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan;1. Department of Hematology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan;2. Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan;3. Group of Quantum Immunology, Institute for Quantum Life Science, National Institute for Quantum and Radiological Science and Technology, Chiba, Japan;4. Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan;5. Division of Molecular Neuroimmunology, Department of Homeostatic Regulation, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan;6. Division of Biological Response Analysis, Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号